Triflusal Triflusal Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA). Trade names include Disgren, Grendis, Aflen and Triflux. Triflusal is a selective platelet antiaggregant through; Triflusal is indicated for; In the 2008 guidelines for stroke management from the European Stroke Organization, triflusal was for the first time recommended as lone therapy, as an alternative to acetylsalicylic acid
Fluoroacetic acid Fluoroacetic acid Fluoroacetic acid is a chemical compound with formula CHFCOOH. The sodium salt, sodium fluoroacetate, is used as a pesticide. It inhibits the aconitase step of the citric acid cycle. Fluoroacetate occurs naturally in at least 40 plants in Australia, Brazil, and Africa. It is one of only five known organic fluorine-containing natural products. It was first identified in "Dichapetalum cymosum", commonly known as gifblaar (Afrikaans) or poison leaf, by Marais in 1944. As early as 1904, colonists in Sierra Leone used extracts of "Chailletia toxicaria", which also contains fluoroacetic acid or its salts, to poison rats. Several native